JP2020513016A5 - - Google Patents

Download PDF

Info

Publication number
JP2020513016A5
JP2020513016A5 JP2019554855A JP2019554855A JP2020513016A5 JP 2020513016 A5 JP2020513016 A5 JP 2020513016A5 JP 2019554855 A JP2019554855 A JP 2019554855A JP 2019554855 A JP2019554855 A JP 2019554855A JP 2020513016 A5 JP2020513016 A5 JP 2020513016A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
antibacterial
composition according
synthetic cationic
antimicrobial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2019554855A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020513016A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/026322 external-priority patent/WO2018187617A1/en
Publication of JP2020513016A publication Critical patent/JP2020513016A/ja
Publication of JP2020513016A5 publication Critical patent/JP2020513016A5/ja
Priority to JP2023028902A priority Critical patent/JP7656643B2/ja
Priority to JP2025049135A priority patent/JP2025090864A/ja
Pending legal-status Critical Current

Links

JP2019554855A 2017-04-06 2018-04-05 能力と安全性が増強された組成物および抗菌合成カチオン性ポリペプチド類を局所的に適用する使用 Pending JP2020513016A (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2023028902A JP7656643B2 (ja) 2017-04-06 2023-02-27 能力と安全性が増強された組成物および抗菌合成カチオン性ポリペプチド類を局所的に適用する使用
JP2025049135A JP2025090864A (ja) 2017-04-06 2025-03-24 能力と安全性が増強された組成物および抗菌合成カチオン性ポリペプチド類を局所的に適用する使用

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762482630P 2017-04-06 2017-04-06
US62/482,630 2017-04-06
PCT/US2018/026322 WO2018187617A1 (en) 2017-04-06 2018-04-05 Compositions and uses of locally applied antimicrobials with enhanced performance and safety

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023028902A Division JP7656643B2 (ja) 2017-04-06 2023-02-27 能力と安全性が増強された組成物および抗菌合成カチオン性ポリペプチド類を局所的に適用する使用

Publications (2)

Publication Number Publication Date
JP2020513016A JP2020513016A (ja) 2020-04-30
JP2020513016A5 true JP2020513016A5 (cg-RX-API-DMAC7.html) 2021-05-06

Family

ID=63712780

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2019554855A Pending JP2020513016A (ja) 2017-04-06 2018-04-05 能力と安全性が増強された組成物および抗菌合成カチオン性ポリペプチド類を局所的に適用する使用
JP2023028902A Active JP7656643B2 (ja) 2017-04-06 2023-02-27 能力と安全性が増強された組成物および抗菌合成カチオン性ポリペプチド類を局所的に適用する使用
JP2025049135A Pending JP2025090864A (ja) 2017-04-06 2025-03-24 能力と安全性が増強された組成物および抗菌合成カチオン性ポリペプチド類を局所的に適用する使用

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2023028902A Active JP7656643B2 (ja) 2017-04-06 2023-02-27 能力と安全性が増強された組成物および抗菌合成カチオン性ポリペプチド類を局所的に適用する使用
JP2025049135A Pending JP2025090864A (ja) 2017-04-06 2025-03-24 能力と安全性が増強された組成物および抗菌合成カチオン性ポリペプチド類を局所的に適用する使用

Country Status (11)

Country Link
US (3) US11285189B2 (cg-RX-API-DMAC7.html)
EP (1) EP3606543A4 (cg-RX-API-DMAC7.html)
JP (3) JP2020513016A (cg-RX-API-DMAC7.html)
KR (2) KR20200018400A (cg-RX-API-DMAC7.html)
CN (1) CN110740744A (cg-RX-API-DMAC7.html)
AU (2) AU2018249552A1 (cg-RX-API-DMAC7.html)
BR (1) BR112019020781A2 (cg-RX-API-DMAC7.html)
CA (1) CA3058901C (cg-RX-API-DMAC7.html)
MX (2) MX393548B (cg-RX-API-DMAC7.html)
SG (1) SG11201909016TA (cg-RX-API-DMAC7.html)
WO (1) WO2018187617A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX344635B (es) 2012-03-23 2017-01-04 Amicrobe Inc Composiciones y usos de materiales antimicrobianos con propiedades compatibles con el tejido.
CN110740744A (zh) 2017-04-06 2020-01-31 艾麦克罗比公司 性能和安全性增强的局部施用的抗微生物剂的组合物和应用
JP2023501385A (ja) * 2019-11-08 2023-01-18 ユニバーシティ オブ ピッツバーグ - オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション 抗微生物ペプチドを含む組成物
CN115397454A (zh) * 2020-03-31 2022-11-25 立美基股份有限公司 通过辐照对自组装肽进行灭菌
WO2021207164A1 (en) * 2020-04-08 2021-10-14 Amicrobe, Inc. Compositions and uses of locally applied synthetic amino acid polymers for prevention and treatment of viral infections
US12371463B2 (en) 2021-04-20 2025-07-29 University of Pittsburgh—of the Commonwealth System of Higher Education Methods and compositions for treatment of antibiotic-resistant bacterial infections
WO2026060306A1 (en) * 2024-09-13 2026-03-19 Macro Biologics, Inc. Compositions and uses of locally applied synthetic cationic and hydrophobic amino acid block copolymers, for prevention and treatment of bacterial and fungal infections

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5636643A (en) 1991-11-14 1997-06-10 Wake Forest University Wound treatment employing reduced pressure
US6686446B2 (en) 1998-03-19 2004-02-03 The Regents Of The University Of California Methods and compositions for controlled polypeptide synthesis
US6632922B1 (en) 1998-03-19 2003-10-14 The Regents Of The University Of California Methods and compositions for controlled polypeptide synthesis
US6680365B1 (en) 1998-03-19 2004-01-20 The Regents Of The University Of California Methods and compositions for controlled polypeptide synthesis
TW570805B (en) 1998-09-01 2004-01-11 Hoffmann La Roche Water-soluble pharmaceutical composition in an ionic complex
WO2000050006A2 (en) 1999-02-26 2000-08-31 Chiron Corporation Microemulsions with adsorbed macromoelecules and microparticles
US20030138453A1 (en) 2000-09-28 2003-07-24 O'hagan Derek Microparticles for delivery of heterologous nucleic acids
US6835536B2 (en) * 2001-08-21 2004-12-28 Micrologix Biotech Inc. Antimicrobial cationic peptides and formulations thereof
WO2003020797A1 (en) 2001-08-30 2003-03-13 The Regents Of The University Of California Transition metal initiators for controlled poly (beta-peptide) synthesis from beta-lactam monomers
JP2003171463A (ja) 2001-12-06 2003-06-20 Chisso Corp ポリリジン及びその製造法
CA2443472A1 (en) 2002-02-07 2003-08-14 Ophtecs Corporation Liquid formulation for contact lenses
DK1585548T3 (en) 2002-12-09 2018-09-03 Abraxis Bioscience Llc COMPOSITIONS AND PROCEDURES FOR THE DELIVERY OF PHARMACOLOGICAL AGENTS
WO2005005436A2 (en) 2003-07-11 2005-01-20 Theravance, Inc. Cross-linked glycopeptide-cephalosporin antibiotics
WO2005018701A1 (en) 2003-08-25 2005-03-03 Kane Biotech Inc. Synergistic antimicrobial compositions and methods of inhibiting biofilm formation
CA2550872C (en) 2003-12-30 2016-05-03 Stig Bengmark Surface protection of exposed biological tissues
EP1722819B1 (en) 2004-03-12 2007-12-26 Intercell AG Method for solubilising peptide mixtures
DK1927597T3 (en) 2004-08-18 2017-02-13 Novabiotics Ltd ANTIBACTERIAL PEPTIDES
KR20080023218A (ko) 2005-06-06 2008-03-12 노보자임스 에이/에스 항균성을 가진 폴리펩티드 및 그것을 코딩하는폴리뉴클레오티드
US20080139450A1 (en) 2005-07-01 2008-06-12 Srinivasa Madhyastha Antimicrobial Compositions and Uses Thereof
US20070190110A1 (en) 2006-02-10 2007-08-16 Pameijer Cornelis H Agents and devices for providing blood clotting functions to wounds
KR101475447B1 (ko) 2006-12-01 2014-12-23 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 자기-조립 블록 코폴리머의 베시클 그리고 그것의 제조 및 사용 방법
JP2010531189A (ja) 2007-06-25 2010-09-24 リポペプチド・アクチエボラーグ 新しい医療用製品
US20090081249A1 (en) 2007-08-27 2009-03-26 Massachusetts Institute Of Technology Bi-Functional Polymer-Attached Inhibitors of Influenza Virus
US20110098344A1 (en) 2008-06-19 2011-04-28 Nippon Shinyaku Co., Ltd. Drug carrier
CN102256613B (zh) 2008-10-20 2014-09-10 莫伊莱麦屈克斯公司 用于治疗或者预防粘连的多肽
CA2750340C (en) 2009-01-23 2017-09-19 Kane Biotech Inc. Biofilm-removing antimicrobial compositions and uses thereof
GB0905451D0 (en) 2009-03-31 2009-05-13 Novabiotics Ltd Biofilms
DK2563916T3 (en) 2010-04-27 2015-10-05 Lysando Ag METHOD FOR REDUCING biofilms
EP2608800B1 (en) 2010-08-23 2017-01-18 The Regents of The University of California Compositions and uses of materials with high antimicrobial activity and low toxicity
CN103370087A (zh) * 2011-01-19 2013-10-23 目立康株式会社 隐形眼镜用液体制剂
US9781949B2 (en) 2011-03-31 2017-10-10 The University Of Massachusetts Antimicrobial delivery systems, methods of manufacture, and methods of use thereof
MX344635B (es) 2012-03-23 2017-01-04 Amicrobe Inc Composiciones y usos de materiales antimicrobianos con propiedades compatibles con el tejido.
DE102014101663A1 (de) 2014-02-11 2015-08-13 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Synthetische artifizielle Peptide mit antimikrobieller Wirkung
EP3194422B1 (en) 2014-09-19 2020-04-29 Tensive Controls, Inc. Anti-microbial peptides
AU2015338969B2 (en) * 2014-10-30 2020-08-27 Biomet Manufacturing, Llc Methods of preventing surgical site infections
JP2016113373A (ja) * 2014-12-11 2016-06-23 エスポ化学株式会社 抗菌性、抗ウイルス性を有する水溶性組成物
CN110740744A (zh) 2017-04-06 2020-01-31 艾麦克罗比公司 性能和安全性增强的局部施用的抗微生物剂的组合物和应用
WO2019169324A1 (en) 2018-03-02 2019-09-06 January Therapeutics, Inc. Nanoparticle compositions

Similar Documents

Publication Publication Date Title
JP2023054375A5 (cg-RX-API-DMAC7.html)
ES2886460T3 (es) Sales de amonio di-cuaternario hechas de organosilicona y agentes antibacterianos
JP5154933B2 (ja) カチオン性消毒剤組成物および使用方法
CN101048135B (zh) 酚类抗菌剂组合物和使用方法
RU2553363C2 (ru) Антисептические композиции и их применения
AU2016203767B2 (en) Compositions and uses of materials with high antimicrobial activity and low toxicity
JP2015512403A5 (cg-RX-API-DMAC7.html)
ES2343208T3 (es) Gel para el tratamiento de heridas.
US20220370680A1 (en) Chitosan-containing formulations and methods of making and using the same
RU2014137827A (ru) Композиции и применение противомикробных материалов со свойствами биологической совместимости
KR20120022930A (ko) 은 설파디아진 및 키토산을 사용하여 제조한 약용 크림 및 이의 제조 방법
US20250134946A1 (en) Self-assembling amphiphilic peptide hydrogels for treatment of nerve injury
WO2016067283A1 (en) Virucidal compositions comprising tannins for nasal and pulmonary administration
ES2860098T3 (es) Composición para la aplicación nasal
US20240366717A1 (en) Antimicrobial matrix formed from peptide hydrogels
JP5535209B2 (ja) 抗菌組成物
WO2019089657A1 (en) Delivery systems for administration of cationic biological actives
JP6456897B2 (ja) 抗菌性及び創傷治癒促進性を有する創傷治癒剤
AU2021252544A1 (en) Compositions and uses of locally applied synthetic amino acid polymers for prevention and treatment of viral infections
ES2692834B2 (es) Microesferas para el tratamiento de enfermedades de la piel o dermatologicas, osteomusculares y vasculares
CA3188232A1 (en) Antifungal matrix formed from peptide hydrogels
ES2784275B2 (es) Antiséptico de acción prolongada para el lavado higiénico por fricción y lavado pre-quirúrgico de manos
RU2019133628A (ru) Композиции и применения антимикробных средств для местного применения с улучшенными характеристиками и безопасностью
RU2456978C1 (ru) Мазь с фурацилином, лидокаином и дибунолом для комплексного лечения абсцессов и флегмон челюстно-лицевой области
RU2682711C1 (ru) Антисептическое средство